Total pancreatectomy with islet autotransplantation in patients with malignancy: Are we there yet?

Annals of Surgery

Volumn 258, Issue 2, 2013, Pages 219-220

  Dudeja, Vikas ^a   Beilman, Greg J ^a   Vickers, Selwyn M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PROGNOSIS; CANCER RECURRENCE; CHRONIC PANCREATITIS; DIABETES CONTROL; DISEASE ASSOCIATION; DISTANT METASTASIS; EDITORIAL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PANCREAS CANCER; PANCREAS FISTULA; PANCREAS ISLET TRANSPLANTATION; PANCREAS RESECTION; PRIORITY JOURNAL; QUALITY OF LIFE;

DIABETES MELLITUS; FEMALE; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; PANCREATECTOMY; PANCREATIC DISEASES; POSTOPERATIVE COMPLICATIONS;

EID: 84880519557     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31829c4a1b     Document Type: Editorial

References (14)

1. Blondet JJ, Carlson AM, Kobayashi T, et al. The role of total pancreatectomy and islet autotransplantation for chronic pancreatitis. Surg Clin North Am. 2007;87:1477-1501.
2. Sutherland DE, Radosevich DM, Bellin MD, et al. Total pancreatectomy and islet autotransplantation for chronic pancreatitis. J Am Coll Surg. 2012;214:409-424; discussion 424-426.
3. Bellin MD, Blondet JJ, Beilman GJ, et al. Predicting islet yield in pediatric patients undergoing pancreatectomy and autoislet transplantation for chronic pancreatitis. Pediatr Diabetes. 2010;11:227-234.
4. Balamurugan AN, Loganathan G, Bellin MD, et al. A new enzyme mixture to increase the yield and transplant rate of autologous and allogeneic human islet products. Transplantation. 2012;93:693-702.
5. Launois B, Franci J, Bardaxoglou E, et al. Total pancreatectomy for ductal adenocarcinoma of the pancreas with special reference to resection of the portal vein and multicentric cancer.World J Surg. 1993;17:122-126; discussion 126-127.
6. Tryka AF, Brooks JR.Histopathology in the evaluation of total pancreatectomy for ductal carcinoma. Ann Surg. 1979;190:373-381.
7. Zhang Y, Frampton AE, Kyriakides C, et al. Loco-recurrence after resection for ductal adenocarcinoma of the pancreas: Predictors and implications for adjuvant chemoradiotherapy. J Cancer Res Clin Oncol. 2012;138:1063-1071.
8. Gianpaolo Balzano PM, Rita Nano, Alessandro Zerbi, et al. Extending indications for islet autotransplantation in pancreatic surgery. Ann Surg. 2013;258:208-218.
9. Dalla Valle R, Mancini C, Crafa P, et al. Pancreatic carcinoma recurrence in the remnant pancreas after a pancreaticoduodenectomy. JOP. 2006;7:473-477.
10. Iyegha UP, Asghar JA, Beilman GJ. Total pancreatectomy and islet autotransplantation as treatment for ampullary adenocarcinoma in the setting of pancreatic ductal disruption secondary to acute necrotizing pancreatitis. A case report. JOP. 2012;13:239-242.
11. Forster S, Liu X, Adam U, et al. Islet autotransplantation combined with pancreatectomy for treatment of pancreatic adenocarcinoma: A case report. Transplant Proc. 2004;36:1125-1126.
12. Lee BW, Jee JH, Heo JS, et al. The favorable outcome of human islet transplantation inKorea: Experiences of 10 autologous transplantations. Transplantation. 2005;79:1568-1574.
13. Liu X, Forster S, Adam U, et al. Islet autotransplantation combined with total pancreatectomy for treatment of pancreatic adenocarcinoma. Transplant Proc. 2001;33:662-663.
14. Ṕerez-Mancera P, Rust A, et al. Corrigendum: The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Nature. 2013;494:266-270.